RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora‐A and BRCA2 in midbody during cytokinesis. Issue 2 (12th February 2013)

• Record Type: Journal Article
• Authors: Yang, Gong; Mercado‐Uribe, Imelda; Multani, Asha S.; Sen, Subrata; Shih, Ie‐Ming; Wong, Kwong‐Kwok; Gershenson, David M.; Liu, Jinsong
• Is Part Of: International journal of cancer. Volume 133:Issue 2(2013:Jul. 15)
• Page Start: 275
• Page End: 285
• Publication Date: 2013-02-12
• Subjects: Cancer -- Periodicals; Cancer -- Prevention -- Periodicals; 616.994
• DOI: 10.1002/ijc.28032
• Languages: English
• ISSNs: 0020-7136

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>The oncogene <italic>RAS</italic> is known to induce genomic instability, leading to cancer development; the underlying mechanism, however, remains poorly understood. To better understand how RAS functions, we measured the activity of the functionally related genes Aurora‐A and BRCA2 in ovarian cancer cell lines and tumor samples containing RAS mutations. We found that Aurora‐A and BRCA2 inversely controlled RAS‐associated genomic instability and ovarian tumorigenesis through regulation of cytokinesis and polyploidization. Overexpression of mutated RAS ablated BRCA2 expression but induced Aurora‐A accumulation at the midbody, leading to abnormal cytokinesis and ultimately chromosomal instability via polyploidy in cancer cells. RAS regulates the expression of Aurora‐A and BRCA2 through dysregulated protein expression of farnesyl protein transferase β and insulin‐like growth factor binding protein 3. Our results suggest that the imbalance in expression of Aurora‐A and BRCA2 regulates RAS‐induced genomic instability and tumorigenesis.</p> </abstract>